FDA to discuss possible regulation of internet promotion of prescription drugs

The FDA announced today in a Federal Register notice that the Agency plans to hold a public hearing to discuss issues regarding the promotion of FDA-regulated products – specifically prescription drugs, prescription biologics, and medical devices – via the Internet and social media. Many in industry feel that guidance from FDA on this issue is long overdue. The FDA Law Blog has more on the story here.